ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025
Relationship between remnant cholesterol inflammatory index and clinical outcome in ischemic stroke patients treated with endovascular thrombectomy.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeGrowing evidence indicates that the remnant cholesterol inflammatory index (RCII) is significantly involved in the pathogenesis of ischemic stroke. In this study, we investigated whether RCII levels are associated with clinical outcomes in large vessel occlusive stroke patients receiving endovascular thrombectomy (EVT) treatment.
methodsWe conducted a retrospective analysis of patients prospectively registered in the stroke databases of two Chinese stroke centers. RCII was derived from lipid profiles and high-sensitivity C-reactive protein levels obtained within 24 h of hospitalization. A poor functional outcome was defined as a modified Rankin Scale score > 2 at 90-day follow-up. The independent relationship between RCII and clinical outcomes was examined through adjusted multivariable logistic regression models.
resultsA total of 935 eligible patients (mean age: 70.4 years; male: 555 [59.4%]) were included. During the 90 days follow-up, 464 patients (49.6%) developed poor outcome. In the multivariable logistic regression analysis, RCII was significantly associated with 90-day poor outcome after EVT (per 1-SD increase: odds ratio [OR], 1.358; 95% confidence interval [CI], 1.080-1.707; P = 0.009; fourth vs. first quartile: OR, 3.926; 95% CI, 2.526-6102; P = 0.001). In addition, subgroup analyses further confirmed these results.
conclusionsOur study demonstrated that elevated RCII levels were significantly associated with 90-day poor functional outcome in anterior circulation large vessel occlusion stroke patients undergoing EVT. Further multicenter studies are warranted to validate these findings across diverse populations and to develop targeted preventive strategies and personalized lifestyle interventions.
Indexed as
Identifiers
41107579What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.